The Interplay of COVID-19 and Hereditary Angioedema: Preventing an Acute Attack
暂无分享,去创建一个
[1] T. Craig,et al. Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management. , 2022, Allergy and asthma proceedings.
[2] M. Riedl,et al. COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications. , 2021, Allergy and asthma proceedings.
[3] G. Karakaya,et al. Effect of COVID-19 on hereditary angioedema activity and quality of life. , 2021, Allergy and asthma proceedings.
[4] D. Launay,et al. COVID‐19 as a trigger of acute attacks in people with hereditary angioedema , 2021, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[5] Y. Zhi,et al. Does hereditary angioedema make COVID-19 worse? , 2020, World Allergy Organization Journal.
[6] M. Riedl,et al. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema , 2018, Clinical Reviews in Allergy & Immunology.
[7] S. Zeerleder,et al. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment , 2016, Annals of medicine.
[8] R. Firszt,et al. Management of acute attacks of hereditary angioedema: role of ecallantide , 2015, Journal of blood medicine.
[9] Aasia I. Ghazi,et al. Hereditary angioedema: epidemiology, management, and role of icatibant , 2013, Biologics : targets & therapy.
[10] Jennifer S. Kim,et al. Hereditary and acquired angioedema. , 2019, Allergy and asthma proceedings.